查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2157194

貓白血病疫苗市場：全球市場預測，2026-2032年

FeLV Vaccine Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，FeLV 疫苗市場將成長至 7.5542 億美元，複合年成長率為 7.92%。

主要市場統計數據
基準年 2025 4.4285億美元
預計年份：2026年 4.7754億美元
預測年份 2032 7.5542億美元
複合年成長率 (%) 7.92%

貓白血病疫苗：執行摘要和戰略背景

貓白血病病毒 (FeLV) 疫苗接種是貓咪預防保健的關鍵環節，尤其對於經常外出活動的貓、接觸過感染或未感染動物的貓，以及其他有感染風險的貓而言。疫苗接種的臨床價值取決於正確的風險評估、檢測程序、產品處理以及對獸醫指導的遵循。此外，還應考慮貓的年齡、健康狀況、當地流行病學情況，以及「必要疫苗接種」和「基於風險的疫苗接種」建議之間的差異。

基於風險的預防措施正在改變貓咪白血病疫苗的接種方式。

貓白血病疫苗接種正從標準化接種轉向個人化預防。獸醫診療方案越來越重視識別感染途徑、根據需要進行疫苗接種前檢測、保持準確的記錄，並根據貓咪生活方式的變化調整疫苗接種計劃。收容所照顧、多貓家庭、救援活動以及負責任的戶外活動仍然是預防的關鍵環節。關於傳播途徑、隔離、檢測和疫苗接種的教育對於減少可避免的感染至關重要。

人工智慧正在增強有關貓白血病病毒的決策和實施。

人工智慧 (AI) 可以透過幫助獸醫診所識別漏種疫苗、根據暴露風險對患者進行分類、自動發送提醒以及檢測臨床和收容所記錄中的模式，從而助力貓白血病 (FeLV) 的預防。決策支援工具還可以幫助解讀病歷並確定後續檢查的優先順序，前提是合格的獸醫專業人員審核其輸出結果。有效實施需要具有代表性的資料、隱私保護、透明的檢驗以及謹慎的管理，以防止提出不恰當的建議。人工智慧應作為臨床判斷和與飼主溝通的補充，而非替代。

區域性見解：預防重點因獸醫基礎設施而異。

在北美，完善的伴侶動物診所和收容所網路為系統性篩檢和基於風險的疫苗接種提供了支持。在拉丁美洲，雖然獸醫服務的覆蓋範圍正在擴大，但預防服務的可及性卻參差不齊，因此成本效益、宣傳活動和教育至關重要。在歐洲，儘管完善的臨床指南和監管體系發揮了積極作用，但預防策略因國家實踐模式和戶外飼養貓的數量而異。在中東，獸醫基礎設施和寵物飼養習慣不盡相同，凸顯了針對具體情況進行教育和改善服務取得途徑計畫的重要性。在非洲，由於醫療保健系統、人與動物的關係以及供應鏈的多樣性，需要採取量身定做的方案。亞太地區擁有高度發展的都市區市場和快速發展的伴侶動物產業，為加強篩檢、記錄保存和全面預防保健提供了機會。

集團洞察：多邊協定和經濟特區塑造准入和標準

東南亞國協可受益於協調一致的獸醫教育、更可靠的冷鏈保障以及統一的檢測和疫苗接種方法。金磚國家成員國的疾病防治系統各不相同，因此在檢測能力、專業培訓和負責任的取得途徑方面的合作將有助於更廣泛的預防工作。歐盟的監管協調和專家網路有助於促進一致的品管和藥物安全監測實踐。七國集團國家通常擁有完善的臨床基礎設施，這為推動數據驅動的預防措施和收容所規程創造了機會。海灣合作理事會國家在其快速發展的寵物護理領域，可以專注於獸醫系統、進口連續性和宣傳活動。北約成員國的國家體系各不相同，但通用的緊急準備原則和跨境獸醫合作可以支持預防服務的連續性。

來自不同國家的見解：國家實踐和准入條件很重要。

澳洲龐大的獸醫網路支持基於風險的疫苗接種，這種接種方式會考慮戶外活動和與多隻貓接觸的情況。巴西和墨西哥可以透過增加預防性照護、教育以及與動物收容所的合作而受益。在加拿大、美國、英國、英國、德國、義大利和西班牙，伴侶動物服務體系已經相當完善，可以透過持續的風險評估、檢測和記錄保存來進一步提升。中國和印度的獸醫環境各不相同，都市化、教育程度、經濟負擔和服務可近性都會影響預防措施的採納。日本和韓國擁有高度發展的寵物照護產業，可以支援數位化提醒、標準化記錄和預防性諮詢。在俄羅斯，由於其獸醫基礎設施地理分散，可靠的配送系統、專業培訓和在地化的宣傳活動至關重要。

FeLV疫苗產業領導者可採取的優先事項

行業領導者應使產品和教育材料與最新的獸醫指南保持一致，清晰地傳達正確的使用方法，並支持可靠的儲存和使用規範。與獸醫醫院、動物收容所、實驗室、公共衛生教育工作者和動物福利組織合作，可以改善檢測和後續工作。數位化工具應優先考慮提醒系統、檢驗的臨床資訊以及與獸醫記錄的互通性。各組織也應加強藥物安全監測，監測獲取障礙，制定符合當地情況的方案，並衡量實際結果，例如檢測完成率、接種計劃的依從性和知情的飼主參與度，同時避免高估疫苗的有效性。

關於貓咪白血病疫苗的調查方法執行摘要

本執行摘要採用定性且基於證據的框架，重點關注貓白血病病毒（FeLV）預防、獸醫護理、醫療服務和負責任的技術應用方面的既定原則。分析涵蓋了不同地區、經濟和政治群體以及國家的影響，同時避免持出未經證實的數字論點。在檢驗臨床、商業性或政策決策之前，應根據現行的國家指南、監管文件、同行評審的獸醫學文獻、監測結果和當地產品資訊來驗證解釋的有效性。

結論：將疫苗接種與檢測和風險管理結合。

貓白血病疫苗接種只有在作為更廣泛的預防策略的一部分時才最為有效，該策略應結合接觸評估、適當的檢測、獸醫諮詢、記錄保存和飼主教育。由於地區和國家之間的差異，靈活實施至關重要，但人工智慧若能負責任地使用，則可為識別挑戰和協調護理提供實際幫助。優先考慮循證溝通、可靠途徑、跨專業協作和可衡量的預防保健流程的領導者，將更有能力加強對不同貓群的貓白血病控制。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：貓白血病疫苗市場：依疫苗類型分類

  • 減毒活病毒疫苗
  • 重組疫苗
  • 次單位疫苗

第8章：貓白血病疫苗市場：依給藥途徑分類

  • 肌肉內部
  • 皮下

第9章：貓白血病疫苗市場：以劑型分類

  • 液體
  • 冷凍乾燥

第10章：貓白血病疫苗市場：依劑量分類

  • 多次給藥
  • 單一劑量

第11章：貓白血病疫苗市場：以最終用戶分類

  • 研究中心
  • 動物診所
  • 動物醫院

第12章：貓白血病疫苗市場：依通路分類

  • 網路商店
    • E Pharmacy
    • 製造商網站
  • 動物診所
  • 動物醫院

第13章：貓白血病疫苗市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章：貓白血病疫苗市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：貓白血病疫苗市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2025年市佔率分析
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Bioveta as
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale SA
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Heska Corporation
  • Hester Biosciences Limited
  • HIPRA SA
  • IDEXX Laboratories Inc.
  • Indian Immunologicals Ltd.
  • Merck & Co. Inc.
  • Phibro Animal Health Corporation
  • Vetoquinol SA
  • Virbac SA
  • Zoetis Inc.

第18章 主要專家

Product Code: MRR-EF0BD2D829EE

The FeLV Vaccine Market is projected to grow by USD 755.42 million at a CAGR of 7.92% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 442.85 million
Estimated Year [2026] USD 477.54 million
Forecast Year [2032] USD 755.42 million
CAGR (%) 7.92%

FeLV Vaccine: Executive Summary and Strategic Context

Feline leukemia virus (FeLV) vaccination is an important component of preventive feline healthcare, particularly for cats with outdoor access, contact with infected or status-unknown animals, or other exposure risks. The clinical value of vaccination depends on appropriate risk assessment, testing practices, product handling, and adherence to veterinary guidance. Decisions should also account for age, health status, local epidemiology, and the distinction between core and risk-based vaccination recommendations.

Risk-Based Prevention Is Reshaping FeLV Vaccination

The FeLV vaccine landscape is shifting toward individualized prevention rather than uniform administration. Veterinary protocols increasingly emphasize identifying exposure pathways, testing cats before vaccination when appropriate, maintaining accurate records, and reviewing schedules as a cat's lifestyle changes. Shelter medicine, multi-cat households, rescue activity, and responsible outdoor access remain important settings for prevention. Education on transmission, quarantine, testing, and vaccination is central to reducing avoidable exposure.

Artificial Intelligence Is Strengthening FeLV Decisions and Delivery

Artificial intelligence can support FeLV prevention by helping practices identify vaccination gaps, segment patients by exposure risk, automate reminders, and detect patterns in clinical and shelter records. Decision-support tools may also assist with interpreting histories and prioritizing follow-up testing, provided that outputs are reviewed by qualified veterinary professionals. Effective adoption requires representative data, privacy safeguards, transparent validation, and careful controls against inappropriate recommendations. AI should augment, not replace, clinical judgment and owner communication.

Regional Insights: Prevention Priorities Differ by Veterinary Infrastructure

In North America, established companion-animal practices and shelter networks support structured testing and risk-based vaccination. Latin America combines growing veterinary access with uneven availability of preventive services, making affordability, outreach, and education important. Europe benefits from developed clinical guidance and regulatory systems, while prevention strategies vary with national practice patterns and outdoor-cat populations. The Middle East presents differing levels of veterinary infrastructure and pet ownership, increasing the value of adaptable education and access programs. Africa requires approaches suited to diverse healthcare capacity, community-animal settings, and supply conditions. Asia-Pacific spans highly developed urban markets and rapidly expanding companion-animal sectors, creating opportunities for stronger screening, recordkeeping, and preventive-care integration.

Group Insights: Multilateral and Economic Blocs Shape Access and Standards

ASEAN countries can benefit from coordinated veterinary education, improved cold-chain reliability, and harmonized approaches to testing and vaccination. BRICS members encompass varied disease-control systems, so collaboration on laboratory capacity, professional training, and responsible access can support broader prevention. The European Union's regulatory coordination and professional networks facilitate consistent quality and pharmacovigilance practices. G7 economies generally have strong clinical infrastructure, creating opportunities to advance data-driven prevention and shelter protocols. GCC countries may focus on veterinary capacity, import continuity, and awareness in rapidly growing pet-care environments. NATO members span diverse national systems, but shared preparedness principles and cross-border veterinary cooperation can support continuity of preventive services.

Country Insights: National Practice and Access Conditions Matter

Australia's extensive veterinary network supports risk-based vaccination, with attention to outdoor and multi-cat exposure. Brazil and Mexico can benefit from expanded preventive-care access, education, and shelter partnerships. Canada, the United States, the United Kingdom, France, Germany, Italy, and Spain have established companion-animal services where consistent risk assessment, testing, and record management can strengthen outcomes. China and India represent diverse veterinary environments in which urbanization, education, affordability, and service availability influence uptake. Japan and South Korea have sophisticated pet-care sectors that can support digital reminders, standardized records, and preventive counseling. Russia's geographically varied veterinary infrastructure makes dependable distribution, professional training, and locally appropriate outreach important.

Actionable Priorities for FeLV Vaccine Industry Leaders

Industry leaders should align products and educational materials with current veterinary guidance, clearly communicate appropriate use, and support reliable storage and administration practices. Partnerships with clinics, shelters, laboratories, public-health educators, and animal-welfare organizations can improve testing and follow-up. Digital tools should prioritize reminder systems, verified clinical information, and interoperability with practice records. Organizations should also strengthen pharmacovigilance, monitor access barriers, tailor programs to regional conditions, and measure practical outcomes such as testing completion, schedule adherence, and informed owner engagement without overstating vaccine performance.

Research Methodology for the FeLV Vaccine Executive Summary

This executive summary uses a qualitative, evidence-led framework focused on established principles of FeLV prevention, veterinary practice, healthcare delivery, and responsible technology adoption. The analysis organizes implications across the required regions, economic and political groups, and countries, while avoiding unsupported numerical claims. Interpretation should be validated against current national guidelines, regulatory documents, peer-reviewed veterinary literature, surveillance findings, and local product information before informing clinical, commercial, or policy decisions.

Conclusion: Integrate Vaccination With Testing and Risk Management

FeLV vaccination is most effective as part of a broader prevention strategy that combines exposure assessment, appropriate testing, veterinary consultation, recordkeeping, and owner education. Regional and national differences make flexible implementation essential, while AI offers practical support for identifying gaps and coordinating care when governed responsibly. Leaders who prioritize evidence-based communication, reliable access, professional collaboration, and measurable preventive-care processes will be better positioned to strengthen FeLV control across diverse feline populations.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. New Revenue Opportunities
  • 3.4. Next-Generation Business Models
  • 3.5. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. FeLV Vaccine Market, by Vaccine Type

  • 7.1. Introduction
  • 7.2. Live Attenuated Vaccine
  • 7.3. Recombinant Vaccine
  • 7.4. Subunit Vaccine

8. FeLV Vaccine Market, by Administration Route

  • 8.1. Introduction
  • 8.2. Intramuscular
  • 8.3. Subcutaneous

9. FeLV Vaccine Market, by Form

  • 9.1. Introduction
  • 9.2. Liquid
  • 9.3. Lyophilized

10. FeLV Vaccine Market, by Dosage

  • 10.1. Introduction
  • 10.2. Multi Dose
  • 10.3. Single Dose

11. FeLV Vaccine Market, by End User

  • 11.1. Introduction
  • 11.2. Research Centers
  • 11.3. Veterinary Clinics
  • 11.4. Veterinary Hospitals

12. FeLV Vaccine Market, by Distribution Channel

  • 12.1. Introduction
  • 12.2. Online Stores
    • 12.2.1. E Pharmacy
    • 12.2.2. Manufacturer Website
  • 12.3. Veterinary Clinics
  • 12.4. Veterinary Hospitals

13. FeLV Vaccine Market, by Region

  • 13.1. Introduction
  • 13.2. Asia-Pacific
  • 13.3. North America
  • 13.4. Latin America
  • 13.5. Europe
  • 13.6. Middle East
  • 13.7. Africa

14. FeLV Vaccine Market, by Group

  • 14.1. Introduction
  • 14.2. ASEAN
  • 14.3. GCC
  • 14.4. European Union
  • 14.5. BRICS
  • 14.6. G7
  • 14.7. NATO

15. FeLV Vaccine Market, by Country

  • 15.1. Introduction
  • 15.2. United States
  • 15.3. Canada
  • 15.4. Mexico
  • 15.5. Brazil
  • 15.6. United Kingdom
  • 15.7. Germany
  • 15.8. France
  • 15.9. Russia
  • 15.10. Italy
  • 15.11. Spain
  • 15.12. China
  • 15.13. India
  • 15.14. Japan
  • 15.15. Australia
  • 15.16. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2025
  • 16.2. Market Concentration Analysis, 2025
    • 16.2.1. Concentration Ratio (CR)
    • 16.2.2. Herfindahl Hirschman Index (HHI)
  • 16.3. Recent Developments & Impact Analysis, 2025
  • 16.4. Product Portfolio Analysis, 2025
  • 16.5. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Bioveta a.s.
  • 17.2. Boehringer Ingelheim International GmbH
  • 17.3. Ceva Sante Animale S.A.
  • 17.4. Dechra Pharmaceuticals PLC
  • 17.5. Elanco Animal Health Incorporated
  • 17.6. Heska Corporation
  • 17.7. Hester Biosciences Limited
  • 17.8. HIPRA S.A.
  • 17.9. IDEXX Laboratories Inc.
  • 17.10. Indian Immunologicals Ltd.
  • 17.11. Merck & Co. Inc.
  • 17.12. Phibro Animal Health Corporation
  • 17.13. Vetoquinol S.A.
  • 17.14. Virbac S.A.
  • 17.15. Zoetis Inc.

18. Key Experts

LIST OF FIGURES

  • FIGURE 1. Global FeLV Vaccine Market, Years Considered for the Study
  • FIGURE 2. Global FeLV Vaccine Market, Research Design
  • FIGURE 3. Global FeLV Vaccine Market, Research Framework
  • FIGURE 4. Global FeLV Vaccine Market, Data Triangulation
  • FIGURE 5. Global FeLV Vaccine Market Size, 2017-2032 (USD Million)
  • FIGURE 6. Global FeLV Vaccine Market Size, by Vaccine Type, 2025 vs 2032 (%)
  • FIGURE 7. Global FeLV Vaccine Market Size, by Vaccine Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 8. Global FeLV Vaccine Market Size, by Administration Route, 2025 vs 2032 (%)
  • FIGURE 9. Global FeLV Vaccine Market Size, by Administration Route, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 10. Global FeLV Vaccine Market Size, by Form, 2025 vs 2032 (%)
  • FIGURE 11. Global FeLV Vaccine Market Size, by Form, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 12. Global FeLV Vaccine Market Size, by Dosage, 2025 vs 2032 (%)
  • FIGURE 13. Global FeLV Vaccine Market Size, by Dosage, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 14. Global FeLV Vaccine Market Size, by End User, 2025 vs 2032 (%)
  • FIGURE 15. Global FeLV Vaccine Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 16. Global FeLV Vaccine Market Size, by Distribution Channel, 2025 vs 2032 (%)
  • FIGURE 17. Global FeLV Vaccine Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 18. Global FeLV Vaccine Market Size, by Region, 2025 vs 2032 (%)
  • FIGURE 19. Global FeLV Vaccine Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 20. Global FeLV Vaccine Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 21. Global FeLV Vaccine Market Size, by Country, 2025 vs 2032 (%)
  • FIGURE 22. Global FeLV Vaccine Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 23. Global FeLV Vaccine Market Share, by Key Player, 2025

LIST OF TABLES

  • TABLE 1. Global FeLV Vaccine Market Segmentation & Coverage
  • TABLE 2. Global FeLV Vaccine Market Size, 2017-2032 (USD Million)
  • TABLE 3. Global FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
  • TABLE 4. Global Live Attenuated Vaccine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 5. Global Live Attenuated Vaccine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 6. Global Live Attenuated Vaccine Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 7. Global Recombinant Vaccine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 8. Global Recombinant Vaccine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 9. Global Recombinant Vaccine Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 10. Global Subunit Vaccine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 11. Global Subunit Vaccine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 12. Global Subunit Vaccine Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 13. Global FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
  • TABLE 14. Global Intramuscular Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 15. Global Intramuscular Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 16. Global Intramuscular Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 17. Global Subcutaneous Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 18. Global Subcutaneous Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 19. Global Subcutaneous Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 20. Global FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 21. Global Liquid Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 22. Global Liquid Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 23. Global Liquid Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 24. Global Lyophilized Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 25. Global Lyophilized Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 26. Global Lyophilized Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 27. Global FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
  • TABLE 28. Global Multi Dose Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 29. Global Multi Dose Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 30. Global Multi Dose Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 31. Global Single Dose Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 32. Global Single Dose Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 33. Global Single Dose Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 34. Global FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 35. Global Research Centers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 36. Global Research Centers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 37. Global Research Centers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 38. Global Veterinary Clinics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 39. Global Veterinary Clinics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 40. Global Veterinary Clinics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 41. Global Veterinary Hospitals Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 42. Global Veterinary Hospitals Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 43. Global Veterinary Hospitals Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 44. Global FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 45. Global Online Stores Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 46. Global Online Stores Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 47. Global Online Stores Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 48. Global E Pharmacy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 49. Global E Pharmacy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 50. Global E Pharmacy Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 51. Global Manufacturer Website Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 52. Global Manufacturer Website Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 53. Global Manufacturer Website Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 54. Global Veterinary Clinics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 55. Global Veterinary Clinics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 56. Global Veterinary Clinics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 57. Global Veterinary Hospitals Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 58. Global Veterinary Hospitals Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 59. Global Veterinary Hospitals Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 60. Global FeLV Vaccine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 61. Asia-Pacific FeLV Vaccine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 62. Asia-Pacific FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
  • TABLE 63. Asia-Pacific FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
  • TABLE 64. Asia-Pacific FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 65. Asia-Pacific FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
  • TABLE 66. Asia-Pacific FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 67. Asia-Pacific FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 68. Asia-Pacific FeLV Vaccine Market Size, by Online Stores, 2017-2032 (USD Million)
  • TABLE 69. North America FeLV Vaccine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 70. North America FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
  • TABLE 71. North America FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
  • TABLE 72. North America FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 73. North America FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
  • TABLE 74. North America FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 75. North America FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 76. North America FeLV Vaccine Market Size, by Online Stores, 2017-2032 (USD Million)
  • TABLE 77. Latin America FeLV Vaccine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 78. Latin America FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
  • TABLE 79. Latin America FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
  • TABLE 80. Latin America FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 81. Latin America FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
  • TABLE 82. Latin America FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 83. Latin America FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 84. Latin America FeLV Vaccine Market Size, by Online Stores, 2017-2032 (USD Million)
  • TABLE 85. Europe FeLV Vaccine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 86. Europe FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
  • TABLE 87. Europe FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
  • TABLE 88. Europe FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 89. Europe FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
  • TABLE 90. Europe FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 91. Europe FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 92. Europe FeLV Vaccine Market Size, by Online Stores, 2017-2032 (USD Million)
  • TABLE 93. Middle East FeLV Vaccine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 94. Middle East FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
  • TABLE 95. Middle East FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
  • TABLE 96. Middle East FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 97. Middle East FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
  • TABLE 98. Middle East FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 99. Middle East FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 100. Middle East FeLV Vaccine Market Size, by Online Stores, 2017-2032 (USD Million)
  • TABLE 101. Africa FeLV Vaccine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 102. Africa FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
  • TABLE 103. Africa FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
  • TABLE 104. Africa FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 105. Africa FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
  • TABLE 106. Africa FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 107. Africa FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 108. Africa FeLV Vaccine Market Size, by Online Stores, 2017-2032 (USD Million)
  • TABLE 109. Global FeLV Vaccine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 110. ASEAN FeLV Vaccine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 111. ASEAN FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
  • TABLE 112. ASEAN FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
  • TABLE 113. ASEAN FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 114. ASEAN FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
  • TABLE 115. ASEAN FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 116. ASEAN FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 117. ASEAN FeLV Vaccine Market Size, by Online Stores, 2017-2032 (USD Million)
  • TABLE 118. GCC FeLV Vaccine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 119. GCC FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
  • TABLE 120. GCC FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
  • TABLE 121. GCC FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 122. GCC FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
  • TABLE 123. GCC FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 124. GCC FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 125. GCC FeLV Vaccine Market Size, by Online Stores, 2017-2032 (USD Million)
  • TABLE 126. European Union FeLV Vaccine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 127. European Union FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
  • TABLE 128. European Union FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
  • TABLE 129. European Union FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 130. European Union FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
  • TABLE 131. European Union FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 132. European Union FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 133. European Union FeLV Vaccine Market Size, by Online Stores, 2017-2032 (USD Million)
  • TABLE 134. BRICS FeLV Vaccine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 135. BRICS FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
  • TABLE 136. BRICS FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
  • TABLE 137. BRICS FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 138. BRICS FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
  • TABLE 139. BRICS FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 140. BRICS FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 141. BRICS FeLV Vaccine Market Size, by Online Stores, 2017-2032 (USD Million)
  • TABLE 142. G7 FeLV Vaccine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 143. G7 FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
  • TABLE 144. G7 FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
  • TABLE 145. G7 FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 146. G7 FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
  • TABLE 147. G7 FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 148. G7 FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 149. G7 FeLV Vaccine Market Size, by Online Stores, 2017-2032 (USD Million)
  • TABLE 150. NATO FeLV Vaccine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 151. NATO FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
  • TABLE 152. NATO FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
  • TABLE 153. NATO FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 154. NATO FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
  • TABLE 155. NATO FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 156. NATO FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 157. NATO FeLV Vaccine Market Size, by Online Stores, 2017-2032 (USD Million)
  • TABLE 158. Global FeLV Vaccine Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 159. United States FeLV Vaccine Market Size, 2017-2032 (USD Million)
  • TABLE 160. United States FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
  • TABLE 161. United States FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
  • TABLE 162. United States FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 163. United States FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
  • TABLE 164. United States FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 165. United States FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 166. United States FeLV Vaccine Market Size, by Online Stores, 2017-2032 (USD Million)
  • TABLE 167. Canada FeLV Vaccine Market Size, 2017-2032 (USD Million)
  • TABLE 168. Canada FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
  • TABLE 169. Canada FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
  • TABLE 170. Canada FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 171. Canada FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
  • TABLE 172. Canada FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 173. Canada FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 174. Canada FeLV Vaccine Market Size, by Online Stores, 2017-2032 (USD Million)
  • TABLE 175. Mexico FeLV Vaccine Market Size, 2017-2032 (USD Million)
  • TABLE 176. Mexico FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
  • TABLE 177. Mexico FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
  • TABLE 178. Mexico FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 179. Mexico FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
  • TABLE 180. Mexico FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 181. Mexico FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 182. Mexico FeLV Vaccine Market Size, by Online Stores, 2017-2032 (USD Million)
  • TABLE 183. Brazil FeLV Vaccine Market Size, 2017-2032 (USD Million)
  • TABLE 184. Brazil FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
  • TABLE 185. Brazil FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
  • TABLE 186. Brazil FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 187. Brazil FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
  • TABLE 188. Brazil FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 189. Brazil FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 190. Brazil FeLV Vaccine Market Size, by Online Stores, 2017-2032 (USD Million)
  • TABLE 191. United Kingdom FeLV Vaccine Market Size, 2017-2032 (USD Million)
  • TABLE 192. United Kingdom FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
  • TABLE 193. United Kingdom FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
  • TABLE 194. United Kingdom FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 195. United Kingdom FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
  • TABLE 196. United Kingdom FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 197. United Kingdom FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 198. United Kingdom FeLV Vaccine Market Size, by Online Stores, 2017-2032 (USD Million)
  • TABLE 199. Germany FeLV Vaccine Market Size, 2017-2032 (USD Million)
  • TABLE 200. Germany FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
  • TABLE 201. Germany FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
  • TABLE 202. Germany FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 203. Germany FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
  • TABLE 204. Germany FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 205. Germany FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 206. Germany FeLV Vaccine Market Size, by Online Stores, 2017-2032 (USD Million)
  • TABLE 207. France FeLV Vaccine Market Size, 2017-2032 (USD Million)
  • TABLE 208. France FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
  • TABLE 209. France FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
  • TABLE 210. France FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 211. France FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
  • TABLE 212. France FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 213. France FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 214. France FeLV Vaccine Market Size, by Online Stores, 2017-2032 (USD Million)
  • TABLE 215. Russia FeLV Vaccine Market Size, 2017-2032 (USD Million)
  • TABLE 216. Russia FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
  • TABLE 217. Russia FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
  • TABLE 218. Russia FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 219. Russia FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
  • TABLE 220. Russia FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 221. Russia FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 222. Russia FeLV Vaccine Market Size, by Online Stores, 2017-2032 (USD Million)
  • TABLE 223. Italy FeLV Vaccine Market Size, 2017-2032 (USD Million)
  • TABLE 224. Italy FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
  • TABLE 225. Italy FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
  • TABLE 226. Italy FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 227. Italy FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
  • TABLE 228. Italy FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 229. Italy FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 230. Italy FeLV Vaccine Market Size, by Online Stores, 2017-2032 (USD Million)
  • TABLE 231. Spain FeLV Vaccine Market Size, 2017-2032 (USD Million)
  • TABLE 232. Spain FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
  • TABLE 233. Spain FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
  • TABLE 234. Spain FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 235. Spain FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
  • TABLE 236. Spain FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 237. Spain FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 238. Spain FeLV Vaccine Market Size, by Online Stores, 2017-2032 (USD Million)
  • TABLE 239. China FeLV Vaccine Market Size, 2017-2032 (USD Million)
  • TABLE 240. China FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
  • TABLE 241. China FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
  • TABLE 242. China FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 243. China FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
  • TABLE 244. China FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 245. China FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 246. China FeLV Vaccine Market Size, by Online Stores, 2017-2032 (USD Million)
  • TABLE 247. India FeLV Vaccine Market Size, 2017-2032 (USD Million)
  • TABLE 248. India FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
  • TABLE 249. India FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
  • TABLE 250. India FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 251. India FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
  • TABLE 252. India FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 253. India FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 254. India FeLV Vaccine Market Size, by Online Stores, 2017-2032 (USD Million)
  • TABLE 255. Japan FeLV Vaccine Market Size, 2017-2032 (USD Million)
  • TABLE 256. Japan FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
  • TABLE 257. Japan FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
  • TABLE 258. Japan FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 259. Japan FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
  • TABLE 260. Japan FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 261. Japan FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 262. Japan FeLV Vaccine Market Size, by Online Stores, 2017-2032 (USD Million)
  • TABLE 263. Australia FeLV Vaccine Market Size, 2017-2032 (USD Million)
  • TABLE 264. Australia FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
  • TABLE 265. Australia FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
  • TABLE 266. Australia FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 267. Australia FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
  • TABLE 268. Australia FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 269. Australia FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 270. Australia FeLV Vaccine Market Size, by Online Stores, 2017-2032 (USD Million)
  • TABLE 271. South Korea FeLV Vaccine Market Size, 2017-2032 (USD Million)
  • TABLE 272. South Korea FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
  • TABLE 273. South Korea FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
  • TABLE 274. South Korea FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 275. South Korea FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
  • TABLE 276. South Korea FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 277. South Korea FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 278. South Korea FeLV Vaccine Market Size, by Online Stores, 2017-2032 (USD Million)
  • TABLE 279. Global FeLV Vaccine Market Share, by Key Player, 2025
  • TABLE 280. Global FeLV Vaccine Market, Key Experts